Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk
Ye Lu(Hangzhou Academy of Agricultural Sciences), Daniela Basso(University of Padua), Evangelina López de Maturana, Audrius Ivanauskas(Lithuanian University of Health Sciences), M Lucchesi(Azienda Usl Toscana Centro), Renata Talar‐Wojnarowska(Medical University of Lodz), Frederike Dijk(Amsterdam University Medical Centers), Lívia Archibugi(Vita-Salute San Raffaele University), Maria Chiara Petrone(Vita-Salute San Raffaele University), Luca Morelli(University of Pisa), Manuel Gentiluomo(University of Pisa), Maria Gazouli(National and Kapodistrian University of Athens), Martin Oliverius(Charles University), Franco Bambi(Meyer Children's Hospital), Chiara Corradi(University of Pisa), Yogesh K. Vashist(Society for the History of Technology), Hanneke W.M. van Laarhoven(Dutch Cancer Society), Konstantinos Papiris(Hippocration General Hospital), Krzysztof Jamroziak(Instytut Hematologii i Transfuzjologi), Jakob R. Izbicki(Universität Hamburg), George Theodoropoulos(National and Kapodistrian University of Athens), Martin Loveček(University Hospital Olomouc), Evaristo Maiello(Casa Sollievo della Sofferenza), Giovanni Capretti(Humanitas University), Raffaele Pezzilli(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Susanne Roth(Goethe University Frankfurt), John P. Neoptolemos(University of Liverpool), Emanuele F. Kauffmann(University of Pisa), Mateus Nóbrega Aoki(Fundação Carlos Chagas), Laura Ginocchi(Azienda Usl Toscana Centro), Viktor Hlaváč(Charles University), Giuseppe Vanella(Azienda Ospedaliera Sant'Andrea), Silvia Carrara(IRCCS Humanitas Research Hospital), Péter Hegyi(Semmelweis University), Stefano Ermini(Meyer Children's Hospital), Gregorio Di Franco(University of Pisa), Faik G. Uzunoǧlu(Universität Hamburg), Marta Puzzono(Vita-Salute San Raffaele University), Andrea Mambrini, Cosimo Sperti(University of Padua), Ewa Małecka‐Panas(Medical University of Lodz), Vytautas Kiudelis(Lithuanian University of Health Sciences), Bas Bueno‐de‐Mesquita(University Medical Center Utrecht), Anna Caterina Milanetto(University of Padua), Pavel Souček(National Institute of Public Health), Patrícia Sarlós(Semmelweis University), Beatrice Mohelníková-Duchoňová(University Hospital Olomouc), Casper H.J. van Eijck(Erasmus MC), Kateřina Kolářová(University Hospital Olomouc), Feng Guo(Indiana University Bloomington)
Cited by 20
Related Papers
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
|The Lancet|2017|1.9k
Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE)
|The Lancet Oncology|2013|1.6k
Treatment With the Radiolabeled Somatostatin Analog [ <sup>177</sup> Lu-DOTA <sup>0</sup> ,Tyr <sup>3</sup> ]Octreotate: Toxicity, Efficacy, and Survival
|Journal of Clinical Oncology|2008|1.4k